Is PGEN stock a Buy, Sell, or Hold?

Based on our analysis, PGEN is currently a WAIT with low confidence. 📊 MIXED SIGNALS: PGEN shows conflicting indicators. Wait for confirmation before entering.

What is the fair value of PGEN stock?

Our analysis estimates the fair value range for PGEN to be between $5.47 and $7.03. The current price is $7.17.

What is the analyst price target for PGEN?

The average Wall Street analyst price target for PGEN is $14.50. This implies a potential upside of 102.2% from current levels.

PGEN Stock Analysis: Buy, Sell, or Hold?

PGEN - Precigen, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS

$7.17

-0.03 (-0.42%) ▼

5d: +9.47%

30d: +32.78%

90d: +69.1%

WAIT

LOW Confidence

Protect Your PGEN Gains

Analysis Updated: Aug 24, 2026 12:00 AM ET

Earnings: Aug 04, 2026 0d

Smart Money Accumulation

Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →

Signal fired Aug 20, 2026 at $7.44 · last confirmed Aug 21, 2026

Strength: 7.0/10

Get Alerted When PGEN Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 MIXED SIGNALS: PGEN shows conflicting indicators. Wait for confirmation before entering.

See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: 25.0%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$33.22

Based on 14.5% avg growth

INTRINSIC VALUE TODAY

$20.63

65.2% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: PGEN is currently trading at $7.17, which is considered extended relative to its 30-day fair value range of $5.47 to $7.03. From a valuation perspective, the stock is trading at a discount (Forward PE: 10.5) compared to its historical average (41.0). Remarkably, the market is currently pricing in an annual earnings decline of 36.5% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, PGEN is in a strong uptrend. Immediate support is located at $6.08, while resistance sits at $7.50.

Market Sentiment: PGEN scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $14.50 (+102.2%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED

Historical Trading Range $5.47 - $7.03

Company Quality Score 42/100 (HOLD)

Volume Confirmation HIGH

Confidence Score 28.6%

Protect Your Profits

Holding PGEN? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BEARISH: Price extended above range
BEARISH: Weak technical setup (23/100)
BULLISH: High volume confirmation
BULLISH: Trading 102.2% below Wall St target ($14.50)
WARNING: Composite score 42/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $5.47 - $7.03

Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $6.08

Resistance Level $7.50

Current Trend Strong Uptrend

Technical data as of Aug 24, 2026

Fundamental Context

Forward P/E (Next Year Est.) 10.51

Wall Street Target $14.50 (+102.2%)

Revenue Growth (YoY) 6322.7%

Profit Margin -184.0%

Valuation Discount vs History -36.5% cheaper

PE vs Historical 10.5 vs 41.0 CHEAP

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): -36.5% (market-implied from PE analysis)

1-Year Target $6.45 (-10%)

2-Year Target $5.81 (-19%)

3-Year Target $5.23 (-27%)

3-Yr Target (if PE normalizes) (PE: 11→41) $20.40 (+185%)

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 20.1, Growth: 209.8%) $46.18 (+544%)

Base: (SPY PE: 10.5, Growth: 209.8%) $24.20 (+238%)

Bear: (PE: 8.9, Growth: 209.8%) $20.57 (+187%)

💡 Upside Surprise Potential

If earnings stabilize (0% growth), PE could expand from 10.5 to 41.0

Stabilization Target: $27.98 (+290.2%)

PE Expansion Potential: +290.2%

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: August 24, 2026 7:04 PM ET
Data refreshes hourly during market hours. Next update: 8:04 PM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is PGEN showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

INSIDERS SELLING

Recent Transactions

Randal J Kirk SELL 4772781 shares 2026-03-30

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for PGEN.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
NTLA Intellia Therapeutics Inc	STRONG BUY 29 analysts	$24	39 SELL
LEGN Legend Biotech Corp	STRONG BUY 22 analysts	$49	48 HOLD
SRPT Sarepta Therapeutics Inc	STRONG BUY 26 analysts	$22	37 SELL
REGN Regeneron Pharmaceutical…	STRONG BUY 25 analysts	$840	40 SELL
JAZZ Jazz Pharmaceuticals PLC	STRONG BUY 18 analysts	$281	62 BUY

NTLA Intellia Therapeu…

39 SELL

LEGN Legend Biotech Co…

48 HOLD

SRPT Sarepta Therapeut…

37 SELL

REGN Regeneron Pharmac…

40 SELL

JAZZ Jazz Pharmaceutic…

62 BUY

Advanced PGEN Option Strategies

Professional options setups generated by AI based on today's PGEN price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for PGEN

PGEN Technical Chart PGEN Price Prediction PGEN Earnings Date PGEN Investment Advisor PGEN Fair Price Analyzer PGEN Options Advisor PGEN Options Chain PGEN Options Analysis PGEN Competitors

Compare PGEN with Peers

PGEN vs TSHA
Which one to buy?

PGEN vs CTMX
Which one to buy?

PGEN vs REPL
Which one to buy?

PGEN vs PHGE
Which one to buy?

PGEN vs GOSS
Which one to buy?

BMY vs PGEN
Winner: BMY

Create New Comparison View All Competitors

Tradestie